Reliable Generation of Induced Pluripotent Stem Cells From Human Lymphoblastoid Cell Lines
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Patient-specific induced pluripotent stem cells (iPSCs) hold great promise for many applications, including disease modeling to elucidate mechanisms involved in disease pathogenesis, drug screening, and ultimately regenerative medicine therapies. A frequently used starting source of cells for reprogramming has been dermal fibroblasts isolated from skin biopsies. However, numerous repositories containing lymphoblastoid cell lines (LCLs) generated from a wide array of patients also exist in abundance. To date, this rich bioresource has been severely underused for iPSC generation. We first attempted to create iPSCs from LCLs using two existing methods but were unsuccessful. Here we report a new and more reliable method for LCL reprogramming using episomal plasmids expressing pluripotency factors and p53 shRNA in combination with small molecules. The LCL-derived iPSCs (LCL-iPSCs) exhibited identical characteristics to fibroblast-derived iPSCs (fib-iPSCs), wherein they retained their genotype, exhibited a normal pluripotency profile, and readily differentiated into all three germ-layer cell types. As expected, they also maintained rearrangement of the heavy chain immunoglobulin locus. Importantly, we also show efficient iPSC generation from LCLs of patients with spinal muscular atrophy and inflammatory bowel disease. These LCL-iPSCs retained the disease mutation and could differentiate into neurons, spinal motor neurons, and intestinal organoids, all of which were virtually indistinguishable from differentiated cells derived from fib-iPSCs. This method for reliably deriving iPSCs from patient LCLs paves the way for using invaluable worldwide LCL repositories to generate new human iPSC lines, thus providing an enormous bioresource for disease modeling, drug discovery, and regenerative medicine applications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Induced pluripotent stem cells (iPSCs) are useful for studying genetic and rare diseases and can be generated by reprogramming immortalized lymphoblastoid cell lines (LCLs) stored in global repositories with detailed genotype and phenotype data.”
In the citing paper
“Previous studies have reported reprogramming efficiencies of 0.0054–0.0216% [6], 0.0015% and 0.002% [5], 0.001–0.06% [4], and 0.03% [47], typically within the range of 0.001 to 0.01%.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induced pluripotent stem cells from a spinal muscular atrophy patient
Ebert, A. D., Yu, J., Rose, F. F., Mattis, V. B., Lorson, C. L., Thomson, J. A., & Svendsen, C. N. (2009) · Nature · doi:10.1038/nature07677 · Cited by 1,441
Self-citationBock, C., Kiskinis, E., Verstappen, G., Gu, H., Boulting, G., Smith, Z. D., Ziller, M., Croft, G. F., Amoroso, M. W., Oakley, D. H., et al. (2011) · Cell · doi:10.1016/j.cell.2010.12.032 · Cited by 1,009
Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick?
Burghes, A. H. M., & Beattie, C. E. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2670 · Cited by 723
Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion
Sareen, D., O’Rourke, J. G., Meera, P., Muhammad, A. K. M. G., Grant, S., Simpkinson, M., Bell, S., Carmona, S., Ornelas, L., Sahabian, A., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3007529 · Cited by 670
Self-citation
Research works printed but not linked: 19
- Robinton, 2012, The promise of induced pluripotent stem cells in research and therapy, Nature, 481, 295, 10.1038/nature10761 · DOI · Paper page
- Atsumi, 2001, Design and development of a catalytic ribonucleoprotein, EMBO J, 20, 5453, 10.1093/emboj/20.19.5453 · DOI
- HD iPSC Consortium, 2012, Induced pluripotent stem cells from patients with Huntington's disease show CAG-repeat-expansion-associated phenotypes, Cell Stem Cell, 11, 264, 10.1016/j.stem.2012.04.027 · DOI · Paper page
- Sareen, 2012, Inhibition of apoptosis blocks human motor neuron cell death in a stem cell model of spinal muscular atrophy, PLoS One, 7, e39113, 10.1371/journal.pone.0039113 · DOI · Paper page
- Yu, 2007, Induced pluripotent stem cell lines derived from human somatic cells, Science, 318, 1917, 10.1126/science.1151526 · DOI · Paper page
- Takahashi, 2007, Induction of pluripotent stem cells from adult human fibroblasts by defined factors, Cell, 131, 861, 10.1016/j.cell.2007.11.019 · DOI · Paper page
- Sie, 2009, Utility of lymphoblastoid cell lines, J Neurosci Res, 87, 1953, 10.1002/jnr.22000 · DOI · Paper page
- Wheeler, 2012, Lymphoblastoid cell lines in pharmacogenomic discovery and clinical translation, Pharmacogenomics, 13, 55, 10.2217/pgs.11.121 · DOI · Paper page
- Choi, 2011, Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripotent stem cells, Blood, 118, 1801, 10.1182/blood-2011-03-340620 · DOI · Paper page
- Rajesh, 2011, Human lymphoblastoid B-cell lines reprogrammed to EBV-free induced pluripotent stem cells, Blood, 118, 1797, 10.1182/blood-2011-01-332064 · DOI · Paper page
- Rao, 2012, Assessing iPSC reprogramming methods for their suitability in translational medicine, J Cell Biochem, 113, 3061, 10.1002/jcb.24183 · DOI · Paper page
- Müller, 2011, A bioinformatic assay for pluripotency in human cells, Nat Methods, 8, 315, 10.1038/nmeth.1580 · DOI · Paper page
- Altmann, 2006, Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes, Proc Natl Acad Sci USA, 103, 14188, 10.1073/pnas.0605985103 · DOI
- Nissenbaum, 2013, Global indiscriminate methylation in cell-specific gene promoters following reprogramming into human induced pluripotent stem cells, Stem Cell Rev, 1, 509
- Wichterle, 2002, Directed differentiation of embryonic stem cells into motor neurons, Cell, 110, 385, 10.1016/S0092-8674(02)00835-8 · DOI · Paper page
- Li, 2005, Specification of motoneurons from human embryonic stem cells, Nat Biotechnol, 23, 215, 10.1038/nbt1063 · DOI · Paper page
- Kim, 2011, Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells, Nat Biotechnol, 29, 1117, 10.1038/nbt.2052 · DOI · Paper page
- Bar-Nur, 2011, Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells, Cell Stem Cell, 9, 17, 10.1016/j.stem.2011.06.007 · DOI · Paper page
- Ruiz, 2012, Identification of a specific reprogramming-associated epigenetic signature in human induced pluripotent stem cells, Proc Natl Acad Sci USA, 109, 16196, 10.1073/pnas.1202352109 · DOI · Paper page
Cited by
Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans
Saykin, A. J., Shen, L., Yao, X., Kim, S., Nho, K., Risacher, S. L., Ramanan, V. K., Foroud, T. M., Faber, K. M., Sarwar, N., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.05.009 · Cited by 306
Workman, M. J., Gleeson, J. P., Troisi, E. J., Estrada, H. Q., Kerns, S. J., Hinojosa, C. D., Hamilton, G. A., Targan, S. R., Svendsen, C. N., & Barrett, R. J. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.12.008 · Cited by 246
“Furthermore, we have previously reported that lymphoblastoid cell lines can be reliably reprogrammed to form iPSCs.(16) Given there are numerous lymphoblastoid cell lines available in well-characterized worldwide repositories that are linked to patient clinical history and long-term genotype-phenotype data,(17) studie…”
BackgroundSelf-citationIshii-Teshima, M., Maeda, K., Hanauchi, K., Asechi, E., Setyawan, D., Niki, T., Nakashima, K., Kurita, H., Numano, R., & Shibata, T. (2025) · PLOS One · doi:10.1371/journal.pone.0333491 · Cited by 4
Metadata
- Authors
- Barrett, R., Ornelas, L., Yeager, N., Mandefro, B., Sahabian, A., Lenaeus, L., Targan, S. R., Svendsen, C. N., & Sareen, D.
- Affiliations
- Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA
- F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, California, USA
- Venue
- Stem Cells Translational Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-10-08
- Volume
- 3
- Issue
- 12
- Pages
- 1429-1434
- ISSN
- 2157-6564
- 2157-6580
- Cited by
- 83
- References
- 4
- Language
- en
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Funders
- California Institute for Regenerative Medicine (RT-02040)
- National Center for Advancing Translational Sciences (UL1TR000124)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Reliable Generation of Induced Pluripotent Stem Cells From Human Lymphoblastoid Cell Lines. https://app.cochat.ai/papers/10.5966/sctm.2014-0121
- The paper
- Barrett, R., Ornelas, L., Yeager, N., Mandefro, B., Sahabian, A., Lenaeus, L., Targan, S. R., Svendsen, C. N., & Sareen, D. (2014). Reliable Generation of Induced Pluripotent Stem Cells From Human Lymphoblastoid Cell Lines. Stem Cells Translational Medicine. https://doi.org/10.5966/sctm.2014-0121
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.